Overview of Glibedal
| Property | Description |
|---|---|
| Active ingredient | Glibenclamide (INN: Glyburide) |
| Form | Tablet (Oral solid dosage form) |
| Pharmacological class | Second-generation Sulfonylurea, Hypoglycemic agent |
| General purpose | Management of high blood sugar (glucose control) |
| Origin | Synthetic derivative compound |
What Type of Medication is Glibedal?
Glibedal is a synthetic, prescription-only medication classified as an oral antidiabetic agent. The drug is formally designated as a second-generation sulfonylurea derivative, which is a category of pharmaceuticals characterized by its potent glucose-lowering effects. The active substance is Glibenclamide, also known as Glyburide internationally. This single-ingredient product is typically available as a tablet for oral administration, combining the active compound with necessary solid pharmaceutical excipients. As a second-generation compound, Glibenclamide is structurally more potent by weight than its first-generation predecessors, allowing for use at lower doses.
Composition: Glibenclamide as an Insulin Secretagogue
The pharmacological activity of Glibedal stems from its core component, Glibenclamide, which acts as an insulin secretagogue. This term means the synthetic compound's primary role is to stimulate the beta-cells in the pancreas to release stored insulin into the bloodstream. Glibenclamide achieves this by binding to and regulating specific molecular structures on the pancreatic cell surface, known as the KATP channels. The regulation of these channels initiates the cellular signal to trigger the secretion of insulin, thereby demonstrating the drug's reliance on the functional capacity of the patient's pancreas.
General Purpose: Managing High Blood Sugar
The overarching purpose of Glibedal is to promote the control of elevated blood sugar levels (hyperglycemia) in adults. By increasing the amount of insulin secreted from the pancreas, the medication assists the body in facilitating the transfer of glucose from the circulating blood into cells. This action helps to normalize the concentration of glucose in the bloodstream, contributing to consistent overall glucose control. The ability to stimulate the body's own insulin release makes it a tool in maintaining metabolic balance for individuals who require adjunctive therapy to achieve their target glycemic goals.
